Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-21

FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) filed by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASERETIC (Enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for VASERETIC (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)